1. Guidance for companies considering the adaptive pathways approach. Available from: https://www.ema.europa.eu/en/documents/regulatory-proceduralguideline/guidance-companies-considering-adaptivepathways-approach_en.pdf.
2. EMA Regulatory Science Strategy to 2025. Available from: https://www.ema.europa.eu/en/about-us/howwe-work/regulatory-science-strategy#regulatoryscience-strategy-to-2025-section.
3. HMA-EMA Joint Big Data Taskforce. Available from: https://www.ema.europa.eu/en/documents/minutes/hma/ema-joint-task-force-big-datasummary-report_en.pdf.
4. The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Guide on Methodological Standards in Pharmacoepidemiology (Revision 9). Available from: https://www.encepp.eu/standards_and_guidances/documents/1.ENCePPMethodsGuideRev.9.pdf.
5. EFPIA’s Position on the Use & Acceptance of RealWorld Evidence by International Markets. Available from: https://www.efpia.eu/media/602956/efpia-rweposition-paper_aug2021.pdf.